Last reviewed · How we verify
NCT03292367
The Procedural Success and Complication Rate of the Left Distal Radial Approach
trial testing ldTRA in Coronary Artery Disease in 200 participants. Completed in 24 February 2018.
19 February 2018
Quick facts
| Lead sponsor | Wonju Severance Christian Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 11 October 2017 |
| Primary completion | 19 February 2018 |
| Estimated completion | 24 February 2018 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- ldTRA
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Radial Artery Injury at Wrist and Hand Level — all drugs for Radial Artery Injury at Wrist and Hand Level →
Sponsor
Wonju Severance Christian Hospital
Who can join
20 and older, any sex, with Coronary Artery Disease or Radial Artery Injury at Wrist and Hand Level. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Left distal transradial approach (ldTRA) can be an attractive alternative route for left radial and right radial artery. Recently, Ferdinand Kiemeneij reported the feasibility and safety of the use of ldTRA. But, there is few studies focused on this issue. Therefore, the purpose of this prospective observational study is to assess the feasibility and safety of the ldTRA for CAG and PCI.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Distal transradial access: a review of the feasibility and safety in cardiovascular angiography and intervention.
Cai G, Huang H, Li F, Shi G, et al · · 2020 · cited 45× · PMID 32758150 · DOI 10.1186/s12872-020-01625-8
Verify or expand the search:
- PubMed search for NCT03292367
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Wonju Severance Christian Hospital trials
Trials by the same sponsor.
- NCT07012499 — QOL and Mental Health Using APD With Remote Monitoring System · NA · enrolling by invitation
- NCT07146178 — Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS · NA · not yet recruiting
- NCT06675396 — Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients · not yet recruiting
- NCT06540430 — Digital Based Home Care Service for Ostomy Patients · NA · not yet recruiting
- NCT07017088 — Efficacy of Leuconostoc Mesenteroides · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03292367 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wonju Severance Christian Hospital
- Last refreshed: 8 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03292367.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing